Literature DB >> 33313833

The association between the pattern of change in N-terminal pro-B-type natriuretic peptide and short-term outcomes in children undergoing surgery for congenital heart disease.

Haiqing Zheng1, Yanqin Cui2, Kuanrong Li1, Jiexin Zhang1, Jiangbo Qu2, Hui Shi1, LiJuan Li2, Huimin Xia3, Xinxin Chen2, Huiying Liang1.   

Abstract

OBJECTIVES: This study aimed to determine whether changes in perioperative N-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with short-term outcomes in children undergoing surgery for congenital heart disease (CHD).
METHODS: We retrospectively included 873 consecutive children with CHD after cardiac surgery. NT-proBNP concentrations were collected from each child prior to and at 1, 12, 36 and 72 h after surgery. The patients had postsurgical follow-ups at 30, 90 and 180 days. The end point was postoperative composite adverse events.
RESULTS: The patients were classified into 3 groups using joint latent class mixture time-to-event models: (i) relatively stable (86.7%), (ii) decreasing (7.2%) and (iii) increasing (6.1%). In total, 257 (29.4%) adverse events occurred. The joint latent class mixture time-to-event models showed that increasing NT-proBNP was strongly associated with adverse events, with adjusted hazard ratio of 2.33 (95% confidence interval 1.52-3.60). Multinomial logistic regression showed that the variables associated with the pattern of change were age, weight at surgery, mode of delivery and cardiopulmonary bypass time.
CONCLUSIONS: The pattern of dynamic postsurgical changes in NT-proBNP may facilitate outcome stratification and identification of a high risk for adverse events.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Adverse events; Children; Congenital heart disease; Joint latent class mixture time-to-event models; N-terminal pro-B-type natriuretic peptide

Mesh:

Substances:

Year:  2021        PMID: 33313833      PMCID: PMC8906720          DOI: 10.1093/icvts/ivaa310

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  20 in total

Review 1.  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.

Authors:  Denise van der Linde; Elisabeth E M Konings; Maarten A Slager; Maarten Witsenburg; Willem A Helbing; Johanna J M Takkenberg; Jolien W Roos-Hesselink
Journal:  J Am Coll Cardiol       Date:  2011-11-15       Impact factor: 24.094

2.  Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).

Authors:  Serge Masson; Roberto Latini; Inder S Anand; Simona Barlera; Laura Angelici; Tarcisio Vago; Gianni Tognoni; Jay N Cohn
Journal:  J Am Coll Cardiol       Date:  2008-09-16       Impact factor: 24.094

3.  Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study.

Authors:  Qu-ming Zhao; Xiao-jing Ma; Xiao-ling Ge; Fang Liu; Wei-li Yan; Lin Wu; Ming Ye; Xue-cun Liang; Jing Zhang; Yan Gao; Bing Jia; Guo-ying Huang
Journal:  Lancet       Date:  2014-04-22       Impact factor: 79.321

4.  Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.

Authors:  Pardeep S Jhund; Inder S Anand; Michel Komajda; Brian L Claggett; Robert S McKelvie; Michael R Zile; Peter E Carson; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2015-04-29       Impact factor: 15.534

5.  Levels of N-terminal-pro-brain natriuretic peptide in congenital heart disease surgery and its value as a predictive biomarker.

Authors:  Maríarosa Pérez-Piaya; Elena Abarca; Virginia Soler; Ana Coca; Marta Cruz; Fernando Villagrá; Silvina Giannivelli; Angel Asensio
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-12-05

Review 6.  BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?

Authors:  Massimiliano Cantinotti; Henry L Walters; Maura Crocetti; Marco Marotta; Bruno Murzi; Aldo Clerico
Journal:  Cardiol Young       Date:  2015-01-20       Impact factor: 1.093

7.  B-type natriuretic peptide levels predict outcomes in infants undergoing cardiac surgery in a lesion-dependent fashion.

Authors:  Rambod Amirnovin; Roberta L Keller; Christina Herrera; Jong-Hau Hsu; Sanjeev Datar; Tom R Karl; Ian Adatia; Peter Oishi; Jeffrey R Fineman
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-20       Impact factor: 5.209

Review 8.  Significance of postoperative arrhythmias in congenital heart disease.

Authors:  Jolien W Roos-Hesselink; Yusuf Karamermer
Journal:  Pacing Clin Electrophysiol       Date:  2008-02       Impact factor: 1.976

9.  Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association.

Authors:  Bradley S Marino; Paul H Lipkin; Jane W Newburger; Georgina Peacock; Marsha Gerdes; J William Gaynor; Kathleen A Mussatto; Karen Uzark; Caren S Goldberg; Walter H Johnson; Jennifer Li; Sabrina E Smith; David C Bellinger; William T Mahle
Journal:  Circulation       Date:  2012-07-30       Impact factor: 29.690

10.  Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease.

Authors:  Vivan J M Baggen; Sara J Baart; Annemien E van den Bosch; Jannet A Eindhoven; Maarten Witsenburg; Judith A A E Cuypers; Jolien W Roos-Hesselink; Eric Boersma
Journal:  J Am Heart Assoc       Date:  2018-03-26       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.